Cancer Immunotherapy

For some time immunotherapy has been heralded as a breakthrough. A large amount of money, the needs of refinement. I do not know what is the most important part of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens.

This thematic volume highlights some key issues and discusses where they may move forward. It has been put together with two leading cancer immunotherapists from two eminent institutions that focus on cancer research.

Engineered cellular vaccines
Blockade of T cell checkpoints.
Serex in the identification of target antigens
New approaches to tumor immunotherapy
Melanoma antigens
Antibodies and chimeric molecules
Tumor Immunosurveillance
Dendritic Cells
Strategies for Tumor Vaccination
DNA vaccines